<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04610047</url>
  </required_header>
  <id_info>
    <org_study_id>NKT-203</org_study_id>
    <nct_id>NCT04610047</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness</brief_title>
  <official_title>A Phase 2b Double-blind, Randomized, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of Norketotifen (NKT) in the Treatment of Acute Uncomplicated Influenza-like Illness (ILI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emergo Therapeutics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Emergo Therapeutics, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a Phase 2b, multi-center, double-blind, randomized, placebo-controlled,&#xD;
      parallel-group study of NKT versus placebo in otherwise healthy adults presenting with acute&#xD;
      uncomplicated ILI due to influenza or other respiratory viruses in a community setting.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 14, 2020</start_date>
  <completion_date type="Anticipated">November 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to alleviation of symptoms</measure>
    <time_frame>14 days</time_frame>
    <description>Time to alleviation of the symptoms of ILI (headache, feverishness/chills, muscle/joint pain, fatigue, cough, sore throat, nasal congestion)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to resolution of fever (body temperature equal to or less than 37ºC)</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of subjects whose symptoms have been alleviated at each time point through Day 14</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in composite symptom score at each time point through Day 14</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body temperature at each time point through Day 14</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to alleviation of individual symptoms (headache, feverishness/chills, muscle/joint pain, fatigue, cough, sore throat, nasal congestion)</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to resumption of normal activity</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of rescue medication (acetaminophen)</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to alleviation of symptoms by confirmed viral pathogen (influenza vs non influenza)</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to resolution of fever by confirmed viral pathogen (influenza vs non influenza)</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Influenza</condition>
  <condition>Influenza -Like Illness</condition>
  <arm_group>
    <arm_group_label>Norketotifen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Norketotifen oral capsules, twice daily for 7 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo oral capsules, twice daily for 7 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Norketotifen</intervention_name>
    <description>Oral capsule</description>
    <arm_group_label>Norketotifen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Oral capsule</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Able to understand the study and comply with all study procedures, and willing to&#xD;
             provide written informed consent prior to the pre-dose examinations&#xD;
&#xD;
          2. Symptoms of ILI including all of the following:&#xD;
&#xD;
               -  Fever ≥38º Celsius (oral)&#xD;
&#xD;
               -  At least one of the following general systemic symptoms associated with ILI are&#xD;
                  present with a severity of moderate or greater: headache, feverishness or chills,&#xD;
                  muscle or joint pain, fatigue&#xD;
&#xD;
               -  At least one of the following respiratory symptoms associated with ILI are&#xD;
                  present with a severity of moderate or greater: cough, sore throat, nasal&#xD;
                  congestion&#xD;
&#xD;
          3. Total symptom severity score (sum of the scores of all 7 individual symptoms) of ≥11&#xD;
             in the predose examinations&#xD;
&#xD;
          4. The time interval between the onset of symptoms and the predose examinations is ≤48&#xD;
             hours.&#xD;
&#xD;
          5. Females of childbearing potential and males agree to use an appropriate method of&#xD;
             contraception as detailed in the protocol&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Known or suspected infection with Severe Acute Respiratory Syndrome-Coronavirus 2&#xD;
             (SARS-CoV2) or Coronavirus Disease 2019 (COVID-19) illness&#xD;
&#xD;
          2. Female subjects who are pregnant, 2 weeks post-partum, or breastfeeding&#xD;
&#xD;
          3. Severe ILI requiring inpatient treatment&#xD;
&#xD;
          4. Any of the following risk factors (according to the CDC's list of People at High Risk&#xD;
             for Developing Serious Flu-Related Complications):&#xD;
&#xD;
               -  Extreme obesity (body mass index ≥40 kg/m^2)&#xD;
&#xD;
               -  Residents of nursing homes or other long-term care facilities&#xD;
&#xD;
               -  American Indians and Alaska natives&#xD;
&#xD;
               -  Asthma&#xD;
&#xD;
               -  Chronic lung disease (such as chronic obstructive pulmonary disease or cystic&#xD;
                  fibrosis)&#xD;
&#xD;
               -  Neurological and neurodevelopmental conditions (including disorders of the brain,&#xD;
                  spinal cord, peripheral nerve, and muscle such as cerebral palsy, epilepsy&#xD;
                  [seizure disorders], stroke, intellectual disability, moderate to severe&#xD;
                  developmental delay, muscular dystrophy, or spinal cord injury)&#xD;
&#xD;
               -  Heart disease (such as congenital heart disease, congestive heart failure, or&#xD;
                  coronary artery disease)&#xD;
&#xD;
               -  Blood disorders (such as sickle cell disease)&#xD;
&#xD;
               -  Endocrine disorders (such as diabetes mellitus)&#xD;
&#xD;
               -  Kidney disorders&#xD;
&#xD;
               -  Liver disorders&#xD;
&#xD;
               -  Metabolic disorders (such as inherited metabolic disorders and mitochondrial&#xD;
                  disorders)&#xD;
&#xD;
               -  Compromised immune system due to disease or medication (such as subjects with&#xD;
                  human immunodeficiency virus or cancer, or those on chronic steroids)&#xD;
&#xD;
          5. Presence of any severe or uncontrolled medical or psychiatric illness&#xD;
&#xD;
          6. History of or current autoimmune disease&#xD;
&#xD;
          7. History of recurrent lower respiratory tract infection&#xD;
&#xD;
          8. Any concurrent infection requiring systemic antimicrobial and/or antiviral therapy&#xD;
&#xD;
          9. Any clinically significant electrocardiogram (ECG) test&#xD;
&#xD;
         10. Received baloxavir, oseltamivir, peramivir, zanamivir, rimantadine, or amantadine&#xD;
             within 30 days prior to the predose examinations&#xD;
&#xD;
         11. Received an investigational monoclonal antibody for a viral disease in the last year&#xD;
             prior to the predose examinations&#xD;
&#xD;
         12. Received ketotifen fumarate, cromolyn sodium, or nedocromil sodium by any route of&#xD;
             administration within 30 days prior to the predose examinations&#xD;
&#xD;
         13. Exposure to an investigational drug within 30 days prior to the predose examinations&#xD;
&#xD;
         14. History of allergic reaction to ketotifen&#xD;
&#xD;
         15. Any prior exposure to norketotifen&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Emergo Therapeutics Clinical Trials</last_name>
    <phone>984-377-5151</phone>
    <phone_ext>204</phone_ext>
    <email>ClinicalTrial@emergotherapeutics.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Precision Trials AZ</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Atria Clinical Research</name>
      <address>
        <city>North Little Rock</city>
        <state>Arkansas</state>
        <zip>72117</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Downtown LA Research Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90017</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>IMMUNOe Research Centers</name>
      <address>
        <city>Centennial</city>
        <state>Colorado</state>
        <zip>80112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Omega Research Debary</name>
      <address>
        <city>DeBary</city>
        <state>Florida</state>
        <zip>32713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Chappel Group Research</name>
      <address>
        <city>Kissimmee</city>
        <state>Florida</state>
        <zip>34744</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>South Florida Research Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33135</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Premier Research Associate</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33165</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Research Institute of South Florida</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33173</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Agile Clinical Research Trials</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30328</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>MediSphere Medical Research Center</name>
      <address>
        <city>Evansville</city>
        <state>Indiana</state>
        <zip>47714</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Horizon Research Group of Opelousas</name>
      <address>
        <city>Eunice</city>
        <state>Louisiana</state>
        <zip>70535</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Continental Clinical Solutions</name>
      <address>
        <city>Towson</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tri-County Research</name>
      <address>
        <city>Sterling Heights</city>
        <state>Michigan</state>
        <zip>48310</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Olive Branch Family Medical Center</name>
      <address>
        <city>Olive Branch</city>
        <state>Mississippi</state>
        <zip>38654</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Clinical Research of South Nevada</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Relief Integrated Health Care</name>
      <address>
        <city>Louisburg</city>
        <state>North Carolina</state>
        <zip>27549</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Buckeye Health and Research</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinical Research Solutions</name>
      <address>
        <city>Middleburg Heights</city>
        <state>Ohio</state>
        <zip>44130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Frontier Clinical Research</name>
      <address>
        <city>Scottdale</city>
        <state>Pennsylvania</state>
        <zip>15683</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Frontier Clinical Research</name>
      <address>
        <city>Smithfield</city>
        <state>Pennsylvania</state>
        <zip>15478</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinovacare Medical Research Center</name>
      <address>
        <city>West Columbia</city>
        <state>South Carolina</state>
        <zip>29169</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Health Concepts</name>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <zip>57702</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinical Research Solutions</name>
      <address>
        <city>Jackson</city>
        <state>Tennessee</state>
        <zip>38305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cedar Health Research</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75251</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Advanced Medical Trials</name>
      <address>
        <city>Georgetown</city>
        <state>Texas</state>
        <zip>78628</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Advanced Medical Group</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>West Houston Clinical Research Service</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77055</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Centex Studies</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77058</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Coastal Medical Group</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77089</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Centex Studies</name>
      <address>
        <city>McAllen</city>
        <state>Texas</state>
        <zip>78504</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Frontier Clinical Research</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26505</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>East Sydney Doctors</name>
      <address>
        <city>Darlinghurst</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Holdsworth House Medical Practice</name>
      <address>
        <city>Darlinghurst</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>AusTrials Wellers Hill</name>
      <address>
        <city>Tarragindi</city>
        <state>Queensland</state>
        <zip>4121</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Western Health, Sunshine Hospital</name>
      <address>
        <city>St Albans</city>
        <state>Victoria</state>
        <zip>3021</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Bridge Family Practice and Skin Clinic</name>
      <address>
        <city>Halls Head</city>
        <state>Western Australia</state>
        <zip>6210</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Captain Stirling Medical Centre</name>
      <address>
        <city>Nedlands</city>
        <state>Western Australia</state>
        <zip>6009</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Southern Clinical Trials Totara</name>
      <address>
        <city>Auckland</city>
        <zip>0640</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lakeland Clinical Trials Waikato</name>
      <address>
        <city>Hamilton</city>
        <zip>3200</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Southern Clinical Trials Tasman Ltd</name>
      <address>
        <city>Nelson</city>
        <zip>7011</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Southern Clinical Trials Remuera</name>
      <address>
        <city>Remuera</city>
        <zip>1050</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lakeland Clinical Trials Rotorua</name>
      <address>
        <city>Rotorua</city>
        <zip>3010</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinical Horizons NZ Ltd</name>
      <address>
        <city>Tauranga</city>
        <zip>3112</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lakeland Clinical Trials Bay of Plenty</name>
      <address>
        <city>Tauranga</city>
        <zip>3118</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>New Zealand</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 26, 2020</study_first_submitted>
  <study_first_submitted_qc>October 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2020</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

